Eris Therapeutics Limited
Pharmaceutical manufacturing company with registered office in Ahmedabad, Gujarat.
2021 | Ahmedabad, Gujarat (India) | Active
Eris Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 3.01 Cr
- Paid Up Capital ₹ 2.58 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 305.00 Cr
About Eris Therapeutics
Eris Therapeutics Limited (ETL) is a Public Limited Indian Non-Government Company incorporated in India on 23 June 2021 (Three years and eight months 10 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.01 Cr and a paid-up capital of Rs 2.58 M.
The company currently has active open charges totaling ₹305.00 Cr.
Kaushal Shah, Inderjeet Negi, Sachin Shah, and One other member serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230GJ2021PLC123519
- Company No.
123519
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Machinery and Equipment
Who are the key members and board of directors at Eris Therapeutics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaushal Shah  | Director | 23-Jun-2021 | Current |
| Inderjeet Negi | Director | 23-Jun-2021 | Current |
| Sachin Shah | Director | 23-Jun-2021 | Current |
| Nita Borkar | Additional Director | 10-Sep-2024 | Current |
Financial Performance of Eris Therapeutics.
Eris Therapeutics Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Eris Therapeutics?
In 2023, Eris Therapeutics had a promoter holding of 99.94% and a public holding of 0.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eris Bionxt Private LimitedKaushal Shah, Inderjeet Negi and 1 more are mutual person
Aprica Healthcare LimitedKaushal Shah and Sachin Shah are mutual person
Eris M. J. Biopharm Private LimitedKaushal Shah is a mutual person
Swiss Parenterals LimitedKaushal Shah and Sachin Shah are mutual person
Eris Oaknet Healthcare Private LimitedNita Borkar is a mutual person
Eris Lifesciences LimitedKaushal Shah and Inderjeet Negi are mutual person
Charges (Loans)
Open Charges
₹305.00 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 170.00 Cr
- Axis Bank Limited : 135.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2023 | Axis Bank Limited | ₹135.00 Cr | Open |
| 08 Aug 2022 | Citi Bank N.A. | ₹150.00 Cr | Open |
| 08 Aug 2022 | Citi Bank N.A. | ₹20.00 Cr | Open |
How Many Employees Work at Eris Therapeutics?
Eris Therapeutics has a workforce of 611 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eris Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Eris Therapeutics
Recent activity within the organization
- Director Appointment
Nita Prasad Borkar was appointed as a Additional Director was appointed as a Additional Director on 10 Sep 2024 & has been associated with this company since 5 months 23 days .
- Charges
A charge with Axis Bank Limited of Rs. 135.00 Cr registered on 15 Dec 2023 with Charge ID 100842809 was modified on 31 Jan 2024.
- Charges
A charge with Axis Bank Limited amounted to Rs. 135.00 Cr with Charge ID 100842809 was registered on 15 Dec 2023.
- Annual General Meeting
Eris Therapeutics Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Charges
A charge with Citi Bank N.A. of Rs. 150.00 Cr registered on 08 Aug 2022 with Charge ID 100612815 was modified on 31 May 2023.
- Balance Sheet
Eris Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
Frequently asked questions
What is the Incorporation or founding date of Eris Therapeutics Limited?
Eris Therapeutics Limited was incorporated on 23 Jun 2021.
What is authorized share capital and paid-up capital of Eris Therapeutics Limited?
The authorized share capital of Eris Therapeutics Limited is ₹ 3.01 Cr and paid-up capital is ₹ 2.58 M.
Who are the current board members & directors of Eris Therapeutics Limited?
Currently 4 directors are associated with Eris Therapeutics Limited.
- Kaushal Kamlesh Shah
- Inderjeet Singh Negi
- Sachin Shah
- Nita Prasad Borkar
What is the registered address of Eris Therapeutics Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Eris Therapeutics Limited is 8Th Floor Commerce House Iv Besides Shell Petrol 100 Feet Road, Prahladnagar India, Ahmedabad, Gujarat, 380015.
What is the corporate identification number (CIN) and company number of Eris Therapeutics Limited?
The corporate identification number (CIN) of Eris Therapeutics Limited is U24230GJ2021PLC123519 and the company number is 123519 as per Ministry of Corporate Affairs (MCA).
How many employees does Eris Therapeutics Limited currently have?
As Per 2023 financial reports, 611 employees are currently employed by Eris Therapeutics Limited.
What are the total open charges for Eris Therapeutics Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Eris Therapeutics Limited amount to ₹ 305.00 Cr.
When was the last Balance Sheet of Eris Therapeutics Limited filed with the ROC?
The most recent Balance Sheet for Eris Therapeutics Limited was filed with the ROC on 31 Mar 2023.